Efficacy Study of Fedovapagon for Nocturia in Men With Benign Prostatic Hyperplasia (BPH)

Status:
Completed

Trial end date:
2017-08-01

Target enrollment:

Participant gender:

This study will investigate the efficacy and safety of fedovapagon in the treatment of nocturia in men with BPH.

Phase 2/Phase 3

Vantia Ltd